These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37299480)

  • 1. Nutrients and Cardiometabolic Health in Type 2 Diabetes.
    Tricò D
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
    ; Leiter LA; Fitchett DH; Gilbert RE; Gupta M; Mancini GB; McFarlane PA; Ross R; Teoh H; Verma S; Anand S; Camelon K; Chow CM; Cox JL; Després JP; Genest J; Harris SB; Lau DC; Lewanczuk R; Liu PP; Lonn EM; McPherson R; Poirier P; Qaadri S; Rabasa-Lhoret R; Rabkin SW; Sharma AM; Steele AW; Stone JA; Tardif JC; Tobe S; Ur E
    Can J Cardiol; 2011; 27(2):124-31. PubMed ID: 21459258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.
    Wang R; Fratiglioni L; Liang Y; Welmer AK; Xu W; Mangialasche F; Johnell K; Qiu C
    PLoS One; 2015; 10(3):e0119582. PubMed ID: 25799502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case presentation and panel discussion: Cardiometabolic risk mitigation.
    Mundi MS; Mechanick JI; Patel JJ; Al-Kazaz M; Garvey WT; Still CD
    JPEN J Parenter Enteral Nutr; 2021 Nov; 45(S2):93-99. PubMed ID: 34897733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149(37):40. PubMed ID: 17918461
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of adverse cardiometabolic consequences of obesity.
    Diaz-Melean CM; Somers VK; Rodriguez-Escudero JP; Singh P; Sochor O; Llano EM; Lopez-Jimenez F
    Curr Atheroscler Rep; 2013 Nov; 15(11):364. PubMed ID: 24048571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
    Mensah GA; Mokdad AH; Ford E; Narayan KM; Giles WH; Vinicor F; Deedwania PC
    Cardiol Clin; 2004 Nov; 22(4):485-504. PubMed ID: 15501618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.
    Malik VS; Popkin BM; Bray GA; Després JP; Hu FB
    Circulation; 2010 Mar; 121(11):1356-64. PubMed ID: 20308626
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular risks in childhood in Hungary.
    Barna M; Horvàth K; Bálint M; Antal M
    Forum Nutr; 2003; 56():247-9. PubMed ID: 15806884
    [No Abstract]   [Full Text] [Related]  

  • 12. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood obesity: a ticking time bomb for cardiovascular disease?
    Logue J; Sattar N
    Clin Pharmacol Ther; 2011 Jul; 90(1):174-8. PubMed ID: 21562487
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
    Padwal RS; Sharma AM
    Can J Cardiol; 2010; 26 Suppl C(Suppl C):18C-20C. PubMed ID: 20847987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?
    Osei K
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4220-2. PubMed ID: 20823471
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease 2019 and Cardiometabolic Disease.
    Kim CW; Aronow WS; Frishman WH
    Cardiol Rev; 2022 May-Jun 01; 30(3):123-128. PubMed ID: 34224449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity.
    Caterson ID; Hubbard V; Bray GA; Grunstein R; Hansen BC; Hong Y; Labarthe D; Seidell JC; Smith SC;
    Circulation; 2004 Nov; 110(18):e476-83. PubMed ID: 15520332
    [No Abstract]   [Full Text] [Related]  

  • 20. The Epidemiology and Economic Burden of Obesity and Related Cardiometabolic Disorders in the United Arab Emirates: A Systematic Review and Qualitative Synthesis.
    Radwan H; Ballout RA; Hasan H; Lessan N; Karavetian M; Rizk R
    J Obes; 2018; 2018():2185942. PubMed ID: 30652030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.